Quotes Vertex Pharmaceuticals Incorporated Sao Paulo

Stocks

VRTX34

BRVRTXBDR001

Pharmaceuticals

Market Closed - Sao Paulo 10:16:17 2026-10-19 EDT			5-day change	1st Jan Change
79.36 ^BRL	-0.30%		+3.77%	+1.43%

10-20	Vertex Pharmaceuticals Incorporated Announces Appointment of Daniel Brennan as Member of the Board of Directors, Audit and Finance Committee	CI
10-15	Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $654 From $653	MT

Stock exchange

Sao Paulo VRTX34 79.36 R$ -0.30% 150K R$

Markets		Price	Change	Volumes
Nasdaq	VRTX	524.52USD	+1.92%	760M $
CBOE	VRTX	524.62USD	+1.96%	35.37M $
Börse Stuttgart	VX1	467.50EUR	+2.53%	40.67K €
Tradegate	VX1	467.00EUR	+1.98%	29.42K €
Xetra	VX1	462.00EUR	+1.35%	12.01K €
Borsa Italiana	1VRTX	445.90EUR	-1.86%	11.15K €
Mexican S.E.	VRTX *	9,366.49MXN	-1.41%	178K $
Boerse Muenchen	VX1	467.10EUR	+1.67%	6.54K €
Deutsche Boerse AG	VX1	456.35EUR	+2.52%	5.48K €
London S.E.	0QZU	512.00USD	+1.50%	1.02K $
CBOE		462.50EUR	+2.55%	925 €
Wiener Boerse	VRTX	462.60EUR	+1.66%	0 €
CBOE	0QZU	453.60EUR	0.00%	0 €
Sao Paulo	VRTX34	79.36BRL	-0.30%	150K R$
Buenos Aires S.E.	VRTX	8,305.00ARS	+3.36%	97.24M $
Buenos Aires S.E.	VRTXD	5.260USD	+0.57%	689.06 $

Quotes 5-day view: Vertex Pharmaceuticals Incorporated

Delayed Quote Sao Paulo

Vertex Pharmaceuticals Incorporated(VRTX34) : Historical Chart (5-day)

	2026-10-13	2026-10-14	2026-10-16	2026-10-19
Last	R$76.48	R$79.04	R$79.60	R$79.36
Volume	37	2	1	1,888
Change	-	+3.35%	+0.71%	-0.30%
Opening	R$77.90	R$79.04	R$79.60	R$79.00
High	R$77.90	R$79.04	R$79.60	R$79.36
Low	R$76.36	R$79.04	R$79.60	R$79.00

Performance

1 day	-0.30%
1 week	+3.77%
Current month	-7.57%
1 month	-7.05%
3 months	+2.90%
6 months	+16.04%
Current year	+1.43%
1 year	+12.92%
3 years	+38.99%
5 years	+146.01%

Volumes

markets

Daily volume

1,888

Estimated daily volume

1,888

Avg. Volume 20 sessions

485

Daily volume ratio

3.89

Avg. Volume 20 sessions BRL

38,489.6

Avg. Volume 20 sessions USD

7,655.66

Record volume 1

244,608

Record volume 2

224,864

Record volume 3

157,616

Capital turnover ratio

Float rotation

Basic data

Market Cap (BRL)

130,443,664,536

Market Cap (USD)

130,443,664,536

Net sales (USD)

12,001,300,000

Number of employees

6,400

Sales / Employee (USD)

1,875,203

Free-Float

99.79%

Free-Float capitalization (BRL)

25,890,661,313

Free-Float capitalization (USD)

130,167,888,819

Average Daily Capital Traded

-.--%

Indicators

Moving average 5 days

78.62

Moving average 20 days

81.81

Moving average 50 days

82.84

Moving average 100 days

80.08

Price spread / (MMA5)

-0.93%

Price spread / (MMA20)

+3.09%

Price spread / (MMA50)

+4.38%

Price spread / (MMA100)

+0.91%

STIM

RSI 9 days

43.06

RSI 14 days

43.92

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	-0.30%	+3.77%	+12.92%	+38.99%	130B
ELI LILLY AND COMPANY	-1.01%	+8.94%	+57.08%	+117.36%	1,144B
JOHNSON & JOHNSON	-0.61%	+3.69%	+33.07%	+68.48%	625B
ABBVIE INC.	-1.48%	+3.81%	+22.73%	+94.76%	511B
ROCHE HOLDING AG	+0.54%	+8.95%	+39.45%	+64.02%	377B
MERCK & CO., INC.	+1.07%	+5.56%	+73.63%	+45.98%	366B
NOVARTIS AG	+0.30%	+6.35%	+21.84%	+49.62%	291B
ASTRAZENECA PLC	-0.03%	+6.04%	+0.40%	+20.94%	262B
AMGEN INC.	-0.14%	+6.18%	+44.51%	+57.22%	237B
GILEAD SCIENCES, INC.	-1.88%	+3.82%	+24.74%	+97.39%	194B
Average	-0.12%	+6.31%	+33.04%	+65.48%	413.84B
Weighted average by Cap.	+0.06%	+6.91%	+39.37%	+78.29%